Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

Trega Biosciences and Northwest Neurologic sign drug discovery agreement

June 20, 1997

Targeted Genetics receives notice of patent allowance for gene delivery technology

June 19, 1997

Preliminary phase III results with CellPro stem cell concentration product

June 17, 1997

Gensia Sicor's GenESA System assigned new indication

June 16, 1997

Guilford granted U.S. patent for polymer drug delivery of anticancer agents

June 13, 1997

Arris and Abbott sign licensing agreement

June 12, 1997

Harvard Medical School and Hoechst Marion Roussel enter research agreement

June 12, 1997

ABS forms alliance with Russian Academy of Sciences

June 11, 1997

Antifibrotic collaboration announced by ArQule and FibroGen

June 11, 1997

NitroMed issued U.S. patent covering NO delivery compounds

June 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...